Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,640.00
-10.00 (-0.15%)
At close: May 29, 2026

KOSDAQ:036480 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,3413,4463,6304,3623,8524,395
Short-Term Investments
6,0915,9435,4237,3659,0075,539
Cash & Short-Term Investments
9,4329,3889,05311,72712,8599,935
Cash Growth
10.25%3.70%-22.80%-8.80%29.44%-1.17%
Accounts Receivable
4,1445,0243,7794,1313,0402,986
Other Receivables
168.93162.58178.67154.12155.3771.96
Receivables
4,3135,1873,9584,2853,1963,058
Inventory
11,09410,55510,48112,49911,64110,614
Prepaid Expenses
97.697.17106.25171.0735.2632.9
Other Current Assets
6.196.9242.7734.1958.9782.36
Total Current Assets
24,94325,23423,64128,71728,69023,722
Property, Plant & Equipment
29,39529,95031,94432,12433,30335,846
Long-Term Investments
1,4131,1521,3101,4981,2561,327
Other Intangible Assets
354354.51354.8356.77354.83356.3
Long-Term Deferred Tax Assets
899.62849.28574.44734.47134.47355.46
Long-Term Deferred Charges
44.5174.17192.79330.08518.86717.28
Other Long-Term Assets
293.71365.08361.62530.37852.47295.71
Total Assets
57,34357,97958,37964,29065,10962,620
Accounts Payable
996.691,1271,3181,543977.94768.84
Accrued Expenses
604.96512.87494.15711.532,6412,047
Short-Term Debt
1,4851,5001,0005,3192,000700
Current Portion of Long-Term Debt
4,5634,6257502,1254,3501,500
Current Portion of Leases
158.44223.73257.16152.28140.83175.61
Current Income Taxes Payable
----377.59-
Other Current Liabilities
595.7542.94710.73547.67124.03122.82
Total Current Liabilities
8,4038,5324,53010,39810,6115,315
Long-Term Debt
13,50013,50018,12516,37515,50019,850
Long-Term Leases
106.02129.09295.4340.3638.45126.51
Pension & Post-Retirement Benefits
40.09----194.65
Other Long-Term Liabilities
365.9397.04279.04127.98122.51130.67
Total Liabilities
22,41522,55823,23026,94226,27225,616
Common Stock
1,9001,9001,9001,9001,9001,900
Additional Paid-In Capital
3,0853,0853,0853,0853,0853,085
Retained Earnings
26,78327,27727,00529,20430,69328,859
Comprehensive Income & Other
3,1603,1603,1603,1603,1603,160
Shareholders' Equity
34,92835,42135,14937,34938,83737,004
Total Liabilities & Equity
57,34357,97958,37964,29065,10962,620
Total Debt
19,81219,97820,42824,01122,02922,352
Net Cash (Debt)
-10,380-10,589-11,374-12,284-9,170-12,418
Net Cash Per Share
--2786.71-2993.19-3232.58-2413.27-3267.79
Filing Date Shares Outstanding
-3.83.83.83.83.8
Total Common Shares Outstanding
-3.83.83.83.83.8
Working Capital
16,53916,70319,11118,31918,07918,407
Book Value Per Share
-9321.449249.839828.5910220.379737.79
Tangible Book Value
34,57435,06734,79536,99238,48336,647
Tangible Book Value Per Share
-9228.159156.479734.7010127.009644.03
Land
2,9822,9822,9822,9822,9825,335
Buildings
15,31515,45716,02616,59617,16717,741
Machinery
10,76511,09512,3229,44910,67910,440
Construction In Progress
74.3574.3574.352,9092,3022,038